Abstract
Mast cells are abundant at the periphery of the majority of solid tumors where they typically promote angiogenesis and enhance tumor growth. However, there is some evidence from epidemiological studies that allergic disease reduces cancer risk. In the context of infection, mast cell activation with Toll-like receptor (TLR) agonists induces the production of multiple mediators which mobilize and activate known anti-tumor effector cells. TLR agonists can also be effective in tumor immunotherapy. We demonstrate that the TLR2 agonist Pam3CSK4 is tumor inhibitory and mediates its effects via mast cell activation and reversal of the normal pro-tumorigenic activity of mast cells. TLR2 agonist treatment decreased B16.F10 tumor growth in wild-type mice, but not in mast cell deficient Kit W-sh/W-sh mice. Tumor growth inhibition following TLR2 agonist administration was restored in Kit W-sh/W-sh mice by local reconstitution with wild-type, but not TLR2-deficient mast cells. Mast cell dependent tumor growth inhibition occurred independently of tumor necrosis factor (TNF) production and was not associated with direct tumor cytotoxicity or degranulation in vitro. Tumor growth inhibition was associated with mast cell dependent recruitment of natural killer (NK) and T cells. This study demonstrates that local mast cell activation provides a novel opportunity to modify the tumor microenvironment for successful cancer immunotherapy. Supported by the CCSRI and CIHR. S.A.O is a recipient of support from the Nova Scotia Health Research Foundation.
Highlights
Mast cells are abundant at the periphery of the majority of solid tumors where they typically promote angiogenesis and enhance tumor growth
In the context of infection, mast cell activation with Toll-like receptor (TLR) agonists induces the production of multiple mediators which mobilize and activate known anti-tumor effector cells
We demonstrate that the TLR2 agonist Pam3CSK4 is tumor inhibitory and mediates its effects via mast cell activation and reversal of the normal protumorigenic activity of mast cells
Summary
Mast cells are abundant at the periphery of the majority of solid tumors where they typically promote angiogenesis and enhance tumor growth. Local Toll-like receptor-mediated mast cell activation inhibits melanoma growth SA Oldford1,2*, ID Haidl1,2, MA Howatt1,2, CA Leiva1,2, B Johnston1,2,3, JS Marshall1,2 From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2009 Halifax, Canada.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.